Reclassification calibration test for censored survival data: performance and comparison to goodness-of-fit criteria

por Demler, Olga V., Paynter, Nina P., Cook, Nancy R.
Publicado 2018

External Validation of a Risk Score for Major Toxicity Among Nonsteroidal Anti‐Inflammatory Drug Users: Real‐World Application

por Solomon, Daniel H., Paynter, Nina P., Guan, Hongshu, Kremer, Joel M.
Publicado 2020

Lifetime Risk of Cardiovascular Disease Among Individuals With and Without Diabetes Stratified by Obesity Status in the Framingham Heart Study

por Fox, Caroline S., Pencina, Michael J., Wilson, Peter W.F., Paynter, Nina P., Vasan, Ramachandran S., D’Agostino, Ralph B.
Publicado 2008

Accumulation of Metabolic Cardiovascular Risk Factors in Black and White Young Adults Over 20 Years

por Paynter, Nina P., Kiefe, Catarina I., Lewis, Cora E., Loria, Catherine M., Goff, David C., Lloyd‐Jones, Donald M.
Publicado 2015

Socioeconomic Status and Incident Type 2 Diabetes Mellitus: Data from the Women's Health Study

por Lee, Timothy C., Glynn, Robert J., Peña, Jessica M., Paynter, Nina P., Conen, David, Ridker, Paul M., Pradhan, Aruna D., Buring, Julie E., Albert, Michelle A.
Publicado 2011

Adverse Effects of Low‐Dose Methotrexate in a Randomized Double‐Blind Placebo‐Controlled Trial: Adjudicated Hematologic and Skin Cancer Outcomes in the Cardiovascular Inflammation...

por Vanni, Kathleen M.M., Berliner, Nancy, Paynter, Nina P., Glynn, Robert J., MacFadyen, Jean, Colls, Joshua, Lu, Fengxin, Xu, Chang, Ridker, Paul M., Solomon, Daniel H.
Publicado 2020

Estimating treatment effects for individual patients based on the results of randomised clinical trials

por Dorresteijn, Johannes A N, Visseren, Frank L J, Ridker, Paul M, Wassink, Annemarie M J, Paynter, Nina P, Steyerberg, Ewout W, van der Graaf, Yolanda, Cook, Nancy R
Publicado 2011

Comparison of Cardiovascular Risk Factors for Coronary Heart Disease and Stroke Type in Women

por Leening, Maarten J. G., Cook, Nancy R., Franco, Oscar H., Manson, JoAnn E., Lakshminarayan, Kamakshi, LaMonte, Michael J., Leira, Enrique C., Robinson, Jennifer G., Ridker, Paul M, Paynter, Nina P.
Publicado 2018

Testing the Effects of Disease‐Modifying Antirheumatic Drugs on Vascular Inflammation in Rheumatoid Arthritis: Rationale and Design of the TARGET Trial

por Giles, Jon T., Rist, Pamela M., Liao, Katherine P., Tawakol, Ahmed, Fayad, Zahi A., Mani, Venkatesh, Paynter, Nina P., Ridker, Paul M., Glynn, Robert J., Lu, Fengxin, Broderick, Rachel, Murray, Meredith, Vanni, Kathleen M. M., Solomon, Daniel H., Bathon, Joan M.
Publicado 2021

Differences in Metabolomic Profiles Between Black and White Women and Risk of Coronary Heart Disease: an Observational Study of Women From Four US Cohorts

por Hu, Jie, Yao, Jie, Deng, Shuliang, Balasubramanian, Raji, Jiménez, Monik C., Li, Jun, Guo, Xiuqing, Cruz, Daniel E., Gao, Yan, Huang, Tianyi, Zeleznik, Oana A., Ngo, Debby, Liu, Simin, Rosal, Milagros C., Nassir, Rami, Paynter, Nina P., Albert, Christine M., Tracy, Russell P., Durda, Peter, Liu, Yongmei, Taylor, Kent D., Johnson, W. Craig, Sun, Qi, Rimm, Eric B., Eliassen, A. Heather, Rich, Stephen S., Rotter, Jerome I., Gerszten, Robert E., Clish, Clary B., Rexrode, Kathryn M.
Publicado 2022

Genome-Wide Meta-Analysis Identifies Regions on 7p21 (AHR) and 15q24 (CYP1A2) As Determinants of Habitual Caffeine Consumption

por Cornelis, Marilyn C., Monda, Keri L., Yu, Kai, Paynter, Nina, Azzato, Elizabeth M., Bennett, Siiri N., Berndt, Sonja I., Boerwinkle, Eric, Chanock, Stephen, Chatterjee, Nilanjan, Couper, David, Curhan, Gary, Heiss, Gerardo, Hu, Frank B., Hunter, David J., Jacobs, Kevin, Jensen, Majken K., Kraft, Peter, Landi, Maria Teresa, Nettleton, Jennifer A., Purdue, Mark P., Rajaraman, Preetha, Rimm, Eric B., Rose, Lynda M., Rothman, Nathaniel, Silverman, Debra, Stolzenberg-Solomon, Rachael, Subar, Amy, Yeager, Meredith, Chasman, Daniel I., van Dam, Rob M., Caporaso, Neil E.
Publicado 2011